ES500421A0 - Procedimiento para la fabricacion de medicamentos topicos deindometacina - Google Patents

Procedimiento para la fabricacion de medicamentos topicos deindometacina

Info

Publication number
ES500421A0
ES500421A0 ES500421A ES500421A ES500421A0 ES 500421 A0 ES500421 A0 ES 500421A0 ES 500421 A ES500421 A ES 500421A ES 500421 A ES500421 A ES 500421A ES 500421 A0 ES500421 A0 ES 500421A0
Authority
ES
Spain
Prior art keywords
indometacine
procedure
manufacture
topical medicines
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES500421A
Other languages
English (en)
Spanish (es)
Other versions
ES8201826A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SOLVON ARZNEI VERTRIEB LIZENZ
Original Assignee
SOLVON ARZNEI VERTRIEB LIZENZ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SOLVON ARZNEI VERTRIEB LIZENZ filed Critical SOLVON ARZNEI VERTRIEB LIZENZ
Publication of ES8201826A1 publication Critical patent/ES8201826A1/es
Publication of ES500421A0 publication Critical patent/ES500421A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
ES500421A 1980-02-18 1981-02-18 Procedimiento para la fabricacion de medicamentos topicos deindometacina Granted ES500421A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3006024A DE3006024C2 (de) 1980-02-18 1980-02-18 Topisches, Indomethacin enthaltendes Arzneimittel in Salbenform

Publications (2)

Publication Number Publication Date
ES8201826A1 ES8201826A1 (es) 1982-01-16
ES500421A0 true ES500421A0 (es) 1982-01-16

Family

ID=6094913

Family Applications (1)

Application Number Title Priority Date Filing Date
ES500421A Granted ES500421A0 (es) 1980-02-18 1981-02-18 Procedimiento para la fabricacion de medicamentos topicos deindometacina

Country Status (11)

Country Link
JP (1) JPS6024764B2 (fr)
AT (1) AT373148B (fr)
BE (1) BE887541A (fr)
CH (1) CH645541A5 (fr)
DE (1) DE3006024C2 (fr)
ES (1) ES500421A0 (fr)
FR (1) FR2475897A1 (fr)
GB (1) GB2069334B (fr)
IT (1) IT1136564B (fr)
NL (1) NL8100503A (fr)
SE (1) SE447060B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5815940A (ja) * 1981-07-23 1983-01-29 Eisai Co Ltd ポリプレニル系化合物およびその製造方法ならびにそれを含有する医薬
JPS59227818A (ja) * 1983-06-09 1984-12-21 Mitsubishi Chem Ind Ltd ゲル状軟膏剤
CH643138A5 (de) * 1983-08-29 1984-05-30 Mepha Ag Indomethacin enthaltende, gelartige salbe.
JPS61501566A (ja) * 1984-03-14 1986-07-31 コルビエ−ル　ジエロ−ム 有効成分の可溶化法およびそれにより得られる薬理組成物
JPS60224638A (ja) * 1984-04-23 1985-11-09 Kao Corp 経皮吸収促進剤およびこれを含有する外用剤
JPH07112984B2 (ja) * 1989-04-28 1995-12-06 久光製薬株式会社 泡状エアゾール製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624197A (en) * 1969-09-04 1971-11-30 Philip Schain Water-soluble tissue infiltrating and embedding compositions
BE756975A (fr) * 1970-06-09 1971-04-02 Merck & Co Inc Suppositoires
US4011313A (en) * 1974-06-07 1977-03-08 Syntex (U.S.A.) Inc. Medicament preparations
JPS5320417A (en) * 1976-08-10 1978-02-24 Yamanouchi Pharmaceut Co Ltd New composition of preparation for rectal application
GB2023000B (en) * 1978-06-17 1982-10-13 Kowa Co Antinflammatory analgesic gelled ointments

Also Published As

Publication number Publication date
GB2069334B (en) 1983-10-19
DE3006024C2 (de) 1983-08-04
NL8100503A (nl) 1981-09-16
BE887541A (fr) 1981-06-15
IT8119824A0 (it) 1981-02-18
SE8100623L (sv) 1981-08-19
IT1136564B (it) 1986-09-03
FR2475897B1 (fr) 1984-02-10
FR2475897A1 (fr) 1981-08-21
SE447060B (sv) 1986-10-27
GB2069334A (en) 1981-08-26
ES8201826A1 (es) 1982-01-16
JPS56135413A (en) 1981-10-22
ATA51381A (de) 1982-06-15
CH645541A5 (de) 1984-10-15
JPS6024764B2 (ja) 1985-06-14
AT373148B (de) 1983-12-27
DE3006024A1 (de) 1981-08-20

Similar Documents

Publication Publication Date Title
MX6980E (es) Procedimiento para la produccion de derivados de carboestirilo
ES529265A0 (es) Procedimiento para la fabricacion de derivados de la piperacina
MX6869E (es) Procedimiento para la preparacion de dibenzimidiazoazepinas
AR223422A1 (es) Procedimiento para la confeccion normalizada de calzados
ES502546A0 (es) Procedimiento para la preparacion de nuevas n-ariloxazolidi-nonas-2
AR228468A1 (es) Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas
AR226202A1 (es) Procedimiento para la preparacion de 7-acil-3-yodometil-cefalosporinas
ES529774A0 (es) Procedimiento para la produccion de derivados de 1-sulfo-2-oxoacetidina
MX160977A (es) Procedimiento para la preparacion de cloroformiatos alfa-clorados
ES491455A0 (es) Procedimiento para la fabricacion de medicamentos de dihy- droergotoxina
ES501464A0 (es) Procedimiento para la preparacion de nuevas fenilureas
ES501913A0 (es) Procedimiento para la fabricacion de condensadores en capas
ES507758A0 (es) Un procedimiento para la preparacion de nuevos derivados de quinoleinetanol o quinoleinpropanol utiles como medicamentos
ES500421A0 (es) Procedimiento para la fabricacion de medicamentos topicos deindometacina
ES527205A0 (es) Procedimiento para la produccion de compuestos poliazoicos
AR226915A1 (es) Procedimiento para la produccion de urea
AR227701A1 (es) Procedimiento para la produccion de alpha-haloalquilamidas
ES503975A0 (es) Procedimiento para la preparacion de nuevas fenilureas
ES506440A0 (es) Procedimiento para la fabricacion de nuevos compuestos de b-lactama
ES523006A0 (es) Procedimiento para la produccion de eteres alquil-ter-butilicos
AR226334A1 (es) Procedimiento para fabricar preparados farmaceuticos
ES500071A0 (es) Procedimiento para la preparacion de nuevos 2-nitro-5-feno- xifenil-oxazoles,-oxacinas,-imidazoles,-pirimidinas o-tiazo-les
AR229350A1 (es) Procedimiento para la preparacion de nuevas guanilamidinas
ES505095A0 (es) Procedimiento para la preparacion de nuevas pirazinas
ES505324A0 (es) Procedimiento para la preparacion de 4-carbamoiloxi-oxaza- fosforinas